Tom joined BioSTAT Consultants as a Statistical Consultant in 2008. He has worked for over 35 years in drug discovery and development for the pharmaceutical industry. His experience spans professional and senior managerial responsibilities in statistics, specializing in the nonclinical areas: Pharmaceutical Sciences, Pharmacology, Toxicology, High Throughput Screening, Drug Metabolism, and Genomics. Tom received an undergraduate degree in mathematics from Western Michigan University and graduate degrees in Biostatistics and Mathematics with a Concentration in Statistics from the same institution. He has authored or coauthored over fifty publications, a book, and several book chapters.
Founded in 1994, BioSTAT is a contract statistics organization devoted to providing customized statistical services for toxicology and drug discovery. Our experienced team of skilled professionals provides expertise in the unique issues associated with the toxicological sciences. As a strategic outsourcing alternative, BioSTAT's comprehensive services are tailored to meet the specific needs of individual clients.
The BioSTAT team is trained in Good Laboratory Practices (GLPs) and our services are GLP compliant.
Angela joined BioSTAT Consultants in November 2006. Her professional experience includes early development drug discovery research, as well as pre-clinical work as a study coordinator in developmental and reproductive toxicology. She received her undergraduate degree in biology from the University of Michigan, and a business degree from Cornerstone University. As project coordinator and quality assurance specialist, Angela’s responsibilities are centered around GLP compliance, scheduling, client communication, as well as business development. She is a member of the Society of Quality Assurance, as well as the Mid West Chapter of the Society of Quality Assurance.
Experience Expertise Excellence
Les founded and has been the President and CEO of BioSTAT Consultants, Inc. since its inception in 1994. He has more than 30 years experience in the pharmaceutical industry as a statistician in toxicology and human clinical trials. His undergraduate degrees are in mathematics and economics from Wittenberg University and his graduate degree is in statistics from Virginia Tech. In addition to authoring and co-authoring numerous articles pertaining to the use of statistics in toxicology, he recently served on the “Neurodevelopmental Endpoints Expert Panel” organized by ILSI. Les is an active member of the American Statistical Association and the Society of Toxicology.
Roger joined BioSTAT Consultants in 2001 to provide statistical and programming support for preclinical studies. Roger has over 15 years of experience providing statistical work in the pharmaceutical industry. He received undergraduate training in biology at the University of Nebraska, graduate training in biostatistics at the University of Nebraska and graduate training in business at Baker University. Roger started his statistical career at Pharmaceutical Research Associates as a Statistician in 1998. During his tenure there he was responsible for the analysis of phase 1-3 clinical studies and several post-marketing studies. He was involved in sales presentations of statistical and programming services to potential clients and in the development of system development life cycle documentation for new software programs. During his final year at PRA he helped establish a PK analysis department which was responsible for the analysis of all Phase 1 clinical studies.He is a member of Drug Information Association (DIA) and an avid Husker fan.
News and Events
Thank you to all who visited our Booth at the Society of Toxicology Annual Meeting and Tox Expo in Baltimore!
Society of Toxicology Annual Meeting and Tox Expo
San Antonio, Texas
March 11th-15th 2018
Visit us at Booth #1145